Tag: cancer treatment
Cipla USA Launches Pomalidomide Capsules, Generic Version of Pomalyst®, in All Strengths
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., announced the commercial launch of Pomalidomide Capsules in the United States. The generic equivalent of Bristol Myers Squibb's Pomalyst® is...
Cipla Partners with SBP Group for Next-Gen HER2 Cancer Therapy
Cipla Limited and Sino Biopharmaceutical Limited (SBP Group) announced that SBP Group's subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), has entered into an exclusive license...
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine alongside Merck's immunotherapy drug Keytruda in melanoma patients.
The...
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Advanced Lung Cancer
AstraZeneca has announced it is stopping its Phase III eVOLVE-Lung02 study, which was testing volrustomig combined with chemotherapy as a first-line treatment for metastatic non-small cell...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
